our aims were to determine the symptomatic time prior to a specific diagnosis, the clinical and histological characteristics of the cases of lung cancer diagnosed in a department of internal medicine, and to analyze the survival factors. material and methods. we studied retrospectively all patients ...
The bright news is that the number of deaths from lung cancer in the U.S. has been steadily dropping. At the same time, the average survival times for those who are newly diagnosed have inched up. Currently, researchers are running more than 1,500 clinical trials on lung cancer to test ...
The incidence of symptomatic pneumonitis in patients who had received radiation therapy for breast cancer is low (<1%). Recently, bronchiolitis obliterans organizing pneumonia (BOOP) syndrome has been described as a secondary lung toxicity due to the radiation therapy, which appears beyond the ...
Lung Cancer Survival With Herbal Medicine and Vitamins in a Whole-Systems Approach: Ten-Year Follow-up Data Analyzed With Marginal Structural Models and Propensity Score Methods Integrative Cancer TherapiesMCCULLOCH M, BROFFMAN M, van der LAAN M, et al. Lung cancer survival with herbal medicine ...
Patient's and doctors' delays in the diagnosis of chest tumors. Patients and methods: All patients with known lung cancer (134 cases) seen at the Department of Respiratory Medicine in Gaevle from February 1, 1997, ... H Koyi,G Hillerdal,E Brandén - 《Lung Cancer》 被引量: 186发表: ...
Patients in the single lung cancer group were significantly older than those in the LCF group (67.12 vs. 65.18 years, p < 0.001). The mean survival time of patients with LCF was longer than that of patients with single lung cancer. Following initial lung cancer, the three most common ...
Patients with localized disease have a 59% 5-year survival rate, compared with 32% for those with regional spread and 6% for those with distant metastases.1 By leading to earlier detection and treatment, screening for lung cancer can give patients a greater chance for cure. Research Needs and...
24 The time variable used in the models was survival time from the date of enrollment. Survival times of participants who did not die were censored at the end of the study period. To control for age, sex, and race, all of the models were stratified by 1-year age categories, sex, and...
Mediastinal lymphadenopathy was associated with earlier lung cancer diagnosis compared with no lymphadenopathy (restricted mean survival time ± standard error, 2285 days ± 44 vs 2611 days ± 2, respectively; P < .001). 在...
lung cancer (NSCLC). According to the clinical correlation analysis, ANKRD22 was highly expressed in primary cancerous tissue compared with adjacent cancerous tissue, and high expression levels of ANKRD22 were significantly correlated with relapse and short overall survival time. Knockdown and ...